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Abstract In this study, we examined the association of
fasting serum insulin (FSI) and fasting serum glucose
(FSG) with cognitive impairment in the very elderly
using a sample of Chinese nonagenarians/centenarians.
This study used data from a survey that was conducted in
2005 on all residents aged 90 years or more in a district
with 2,311,709 inhabitants. FSG, FSI, and cognitive
function were analyzed. The sample included 661
unrelated Chinese individuals (aged 90–108 years; mean,
93.52±3.37 years; 67.17 % women; FSI, 6.27±
2.27 mU/mL; FSG levels, 4.46±1.45 mmol/L). The
prevalence of cognitive impairment was 61.81 % and
that of hypoinsulinemia was 31.92 %. Individuals with
hypoinsulinemia showed lower cognitive function scores
(14.81±5.79 vs. 15.78±5.24, t=2.160, P=0.031). No
differences in cognitive function score between different
FSI and FSG groups were significant, and no differences in
FSI and FSG between individuals with and without
cognitive impairment were statistically significant.
Unadjusted multiple logistic regressions showed that
hypoinsulinemia, impaired fasting glucose, or diabetes
did not change the risk of cognitive impairment signif-
icantly. In summary, we found that in elderly subjects,
cognitive function appeared associated with FSI, and
higher FSI may be associated with enhanced cognitive
function.
Keywords Fasting serum insulin . Fasting serum
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Introduction
Type 2 diabetes and its related metabolic disorders
including hyperinsulinemia, insulin resistance, and
hyperglycemia are important conditions in the elderly
(Kesavadev et al. 2003). Recent studies have discov-
ered that the insulin metabolic disorders may be one of
the important risk factors for Alzheimer’s disease
(AD) (Duron and Hanon 2008; Planel et al. 2007).
Some researchers have postulated that independent of
the effect of glucose, the level of hyperinsulinemia
correlates with cognitive decline in the elderly (van
den Berg et al. 2006, 2007). However, other re-
searchers have presented evidence showing no rela-
tionship between insulin levels and cognitive dysfunc-
tion (Kodl and Seaquist 2008; Park 2001; Kern et al.
2001). Thus, the relationship between fasting serum
insulin (FSI) and cognitive dysfunction remains un-
known (van den Berg et al. 2006, 2007; Kodl and
Seaquist 2008; Park 2001; Kern et al. 2001). Several
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additional studies have shown that impaired fasting
glucose and type 2 diabetes and their related metabolic
disorders correlate with vascular dementia rather than
AD (Craft 2009). The association of cognitive function
with FSI and fasting serum glucose (FSG) has been the
focus of many researchers, but no definitive conclusion
has been generated (van den Berg et al. 2006, 2007;
Kodl and Seaquist 2008; Park 2001; Kern et al. 2001).
However, although some evidence of the correlation
exists, no study has examined long-lived subjects. In
this study, we provide evidence from long-lived sub-
jects, which may prove useful in clarifying the associa-
tion of cognitive function with FSI and FSG. We exam-
ine a group of Chinese nonagenarians/centenarians.
Subjects and methods
Study subjects
The methods used have been described previously (Zhou
et al. 2010; Huang et al. 2009). In brief, a cross-sectional
study for age-related diseases was conducted in 870 long-
lived subjects (>90 years), which was a part of the Project
of Longevity and Aging in Dujiangyan (PLAD) and was
based on the Dujiangyan (located in Sichuan Province in
southwest China) 2005 census. The PLAD aimed to in-
vestigate relationships between the environment, lifestyle,
genetics, cognitive function, longevity, and age-related
diseases. The basic health of volunteers was examined by
trained physicians. Results were entered onto a standard
form and included a questionnaire on lifestyles and cogni-
tive function [measured using the 30-item Mini-Mental
State Examination (MMSE)]. FSG and FSI were deter-
mined using the glucose oxidase method and RIAs, re-
spectively. We excluded those who did not complete the
MMSE test or where no information on FSG or FSI was
available. Subjects with a previous diagnosis of diabetes
(they may have used treatments to influence their FSG,
FSI, or insulin resistance (IR)) or receiving diabetes med-
ication were also excluded. Overall, 21 men and 26 wom-
en were excluded from the study because they had already
died ormoved out of the area. Of 262men and 561women
who were interviewed, 38 men and 124 women did not
complete the MMSE test. Those that did not provide FSG
or FSI information or those with a previous diagnosis of
diabetes did not complete MMSEs. Therefore, the study
population ultimately comprised 661 long-lived subjects.
Informed consents were obtained from all participants (and
their legal proxies). The Research Ethics Committee of
Sichuan University approved this study.
Data collection and measurements
Assessment of cognitive function
The methods used to assess cognitive function have
been reported previously (Zhou et al. 2010; Huang et
al. 2009). Cognitive function was measured using the
30-item MMSE, which is a global test that includes
components that test orientation, attention, calculation,
language, and recall. To decrease methodological errors
and assure method reliability, the administrator of the test
was provided with professional training comprising: (1)
reviewing the MMSE procedure and grading system, as
outlined in a short booklet and video; (2) observing a
geriatrician conduct the MMSE on residents who were
not part of the study; and (3) receiving supervision while
conducting the MMSE on residents who were not part of
the study. Individuals who gave consent to participate in
the study were tested using the MMSE. The individuals
were categorized as follows: possible dementia (scores
between 0 and 18), mild cognitive impairment (scores
between 19 and 24), and normal (scores between 25 and
30) (Zhou et al. 2010; Huang et al. 2009; Tombaugh and
McIntyre 1992).
The MMSE relies heavily on visual and auditory
abilities, in particular at advanced ages (Zhou et al.
2010; Huang et al. 2009), and there was a high preva-
lence of visual or hearing impairment among the nona-
genarians and centenarians. Twenty-eight men and 72
women did not complete the MMSE test due to visual or
hearing impairment. To address this issue, these subjects
were excluded at data analysis. In the oldest-old group, only
35 subjects had scores higher than 24 (30 in men and 5 in
women); therefore,wemerged data from subjectswithmild
cognitive impairment and normal cognitive function into an
“impossible” dementia groupwhen the data were analyzed.
Measurement of FSG and FSI
Blood samples for measurement of FSG and FSI were
obtained from all subjects at 08:00 following an over-
night fast. FSG was measured using the glucose oxi-
dase method (glucose B-test, Wako Pure Chemical,
Osaka, Japan) (Kouzuma et al. 2002). FSI levels were
determined using the RIA technique. Sera used to mea-
sure serum insulin concentrations by RIAwere stored at
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−80 °C (Bowsher et al. 1999; Singhal et al. 2005). FSG
and FSI were determined using standard laboratory
techniques (performed by a technician in the bio-
chemistry laboratory of Sichuan University). Abnormal
FSG and FSI levels were defined based on criteria pro-
vided by the China Diabetes Association as follows: nor-
mal FSG, <6.00 mmol/L; IFG, 6.00–7.00 mmol/L; diabe-
tes, >7.00mmol/L; hypo-FSI, <5.00mU/mL; normal FSI,
5–15.00 mU/mL; and hyper-FSI, >15.00 mU/mL (Song
et al. 2011; Xu et al. 2010), respectively.
Assessment of covariates
The methods used have been described previously (Zhou
et al. 2010; Huang et al. 2009). The baseline examination
obtained information on age (years), gender (male/female),
body mass index (BMI), serum uric acid (SUA), and
serum lipid/lipoprotein levels. Blood pressure in the right
arm (sitting or recumbent position) was measured
twice to the nearest 2 mmHg using a standard mercury
sphygmomanometer (Korotkoff phases I andV) by trained
nurses or physicians. Serum lipid/lipoprotein levels (in-
cluding serum triglyceride (TG), total cholesterol (TC),
high density lipoprotein (HDL) cholesterol, and low
density lipoprotein (LDL) cholesterol) and SUA levels
were determined using standard laboratory techniques
(performed by a technician in the biochemistry laboratory
of Sichuan University).
Statistical analyses
All statistical analyses for this study were performed using
the SPSS for Windows software package, version 11.5
(SPSS Inc., Chicago, IL, USA). Comparisons were made
between baseline characteristics of the different FSI
groups (out of all participants, only 5 showed
hyperinsulinemia and 211 showed hypoinsulinemia;
the five individuals with hyperinsulinemia were merged
into the normal insulin group) and between individuals
with and without cognitive impairment using unpaired
Student’s t tests for continuous variables or Pearson Chi
squared or Fisher’s exact tests (where an expected cell
count was <5) for categorical variables. Baseline char-
acteristics between the different FSG groups were also
compared using analysis of variance for continuous
variables. Multiple logistic regression was used to esti-
mate the odds ratio and 95 % confidence interval of
hypoinsulinemia or abnormal FSG as a function of
Table 1 Baseline demographics based on fasting serum glucose (FSG; n=661)
Demographic All (n=661) Fasting serum glucose
Normal (n=587) Impaired fasting glucose (n=33) Diabetes (n=41) χ2 or F P value
Age (years) 93.52±3.37 95.56±3.34 92.79±3.52 93.51±3.62 0.818 0.442
Gender (male/female) 217/444 187/400 15/18 15/26 2.964 0.227
MMSE score 15.48±5.44 15.46±5.45 16.63±5.15 14.90±5.66 0.939 0.392
Cognitive impairment
(yes/no)
409/252 366/221 16/17 15/26 1.599 0.420
BMI (kg/m2) 19.05±3.64 19.11±3.67 18.40±3.40 18.57±3.46 0.956 0.385
DBP (mmHg) 72.59±12.06 72.58±12.03 70.52±12.48 74.46±12.10 0.984 0.374
SBP (mmHg) 139.71±23.31 140.21±22.78 140.36±28.58 135.61±18.91 0.780 0.459
TG (mmol/L) 1.22±0.64 1.23±0.64 0.99±0.32 1.27±0.74 2.264 0.105
TC (mmol/L)* 4.15±0.85 4.18±0.85 3.94±0.82 3.89±0.12 3.170 0.043
HDL (mmol/L) 1.58±0.59 1.59±0.61 1.56±0.43 1.40±0.35 1.932 0.146
LDL (mmol/L) 2.28±0.97 2.30±0.97 2.09±0.57 2.12±0.53 1.282 0.278
SUA (μmol/L)** 318.72±87.01 314.84±81.53 338.91±95.80 357.62±134.16 5.642 0.004
FSI (mU/L) 6.27±2.27 6.24±2.24 6.46±2.58 6.49±2.56 0.359 0.669
Baseline demographics were compared between different SUA groups
SUA serum uric acid, BMI body mass index, FSG fasting blood glucose, HDL high density lipoprotein, LDL low density lipoprotein, TC
total cholesterol, TG triglyceride, SBP systolic blood pressure, DBP diastolic blood pressure
*P<0.05; ** P<0.01 vs. low SUA group using χ2 or Fisher’s exact tests (where an expected cell count was <5) for categorical
variables or unpaired Student’s t tests for continuous variables
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increased risk for increased cognitive impairment. We
adjusted age, gender, and educational levels as general
covariates in model 1. In view of the fact that general or
central adiposity, elevated blood pressure, dyslipidemia,
hyperglycemia, and hyperuricacidemia may be compo-
nents of metabolic syndrome and that they may be
involved in the association of hypoinsulinemia or ab-
normal FSG with cognitive impairment, we adjusted
BMI, serum lipid/lipoprotein, blood pressure, and
SUA in model 2. We adjusted all of these covariates in
model 3. A P value of <0.05 was considered to be
statistically significant, and all P values were two sided.
Results
Baseline characteristics of genotype frequencies
of the IR and cognitive impairment
The sample group included 661 unrelated Chinese (aged
90–108 years; mean, 93.52±3.37 years; 67.3 %women;
FSI, 6.27±2.27 mU/mL; FSG, 4.46±1.45 mmol/L;
MMSE score, 15.49±5.44). In this sample, 409 individ-
uals (61.8 %) were cognitively impaired.
To demonstrate the association between demo-
graphics or clinical characteristics and FSG, the means
(or percentages) of various demographic and clini-
cal characteristics grouped by FSG are shown in
Table 1. Subgroups with impaired fasting glucose
and diabetes showed significantly higher SUA (F=
5.642, P=0.004) and TC (F=3.170, P=0.043)
levels. There were no significant differences be-
tween the different subgroups in other covariates
(age, gender, FSI, serum lipid/lipoprotein levels,
blood pressure, and BMI; see Table 1).
The means (or percentages) of various demographic
or clinical characteristics in the hypoinsulinemia and
normal insulin groups are shown in Table 2 to demon-
strate the association between demographics or clinical
characteristics and FSI. Fewer males showed
hypoinsulinemia compared with females (χ2=5.280,
P=0.029). Individuals with hypoinsulinemia showed
significantly lower SUA (t=4.486, P<0.0001), TC (t=
5.376, P<0.0001), HDL (t=3.321, P=0.010), and LDL
(t=2.353, P=0.027) and higher diastolic blood pressure
(t=1.964, P=0.049) levels. There were no significant
differences between the different subgroups in other
covariates (age, TG, SBP, and BMI; see Table 2).
Table 2 Baseline demographics based on fasting serum insulin (FSI; n=661)





χ2 or t P
Age (years) 93.52±3.37 93.40±3.16 93.57.±3.47 0.598 0.550
Gender (male/female)* 217/444 58/153 158/291 5.280 0.029
MMSE scores* 15.48±5.44 14.81±5.79 15.78±5.24 2.160 0.031
Cognitive impairment (yes/no) 409/252 139/72 268/177 2.960 0.228
BMI (kg/m2) 19.05±3.64 19.17±3.54 18.99±3.69 0.573 0.567
DBP (mmHg)* 72.59±12.06 73.94±11.91 71.96±12.14 1.964 0.049
SBP (mmHg) 139.71±23.31 141.12±21.94 139.38±23.38 0.913 0.932
TG (mmol/L) 1.22±0.64 1.28±0.69 1.19±0.61 1. 598 0.111
TC (mmol/L)** 4.15±0.85 3.99±0.85 4.22±0.84 5.376 <0.0001
HDL (mmol/L)* 1.58±0.59 1.50±0.41 1.61±0.65 3.321 0.010
LDL (mmol/L)* 2.28±0.97 2.16±0.60 2.33±.1.10 2.353 0.027
SUA (μmol/L)** 318.72±87.01 296.75±79.90 328.97±88.37 4.486 <0.0001
FSG (mmol/L) 4.47±1.45 4.49±1.49 4.47±1.44 0.180 0.858
Baseline demographics were compared between different FSG groups
SUA Serum uric acid, BMI body mass index, FSG fasting blood glucose, HDL high density lipoprotein, LDL low density lipoprotein,
TC total cholesterol, TG triglyceride, SBP systolic blood pressure, DBP diastolic blood pressure
*P<0.05; **P<0.01 vs. low SUA group using χ2 or Fisher’s exact tests (where an expected cell count was <5) for categorical variables
and unpaired Student’s t tests for continuous variables
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The means (or percentages) of various demographic
or clinical characteristics grouped by cognitive impair-
ment are shown in Table 3 to demonstrate the associ-
ation between demographics or clinical characteristics
and cognitive impairment. Fewer males showed cog-
nitive impairment compared with females (χ2=56.16,
P<0.0001). Individuals with higher educational levels
showed less cognitive impairment (χ2=95.32, P<
0.0001). Individuals with cognitive impairment
showed higher TC (t=2.098, P=0.036). There were
no significant differences between the different sub-
groups in other covariates (see Table 3).
Association of cognitive impairment with FSG
Among the different FSG groups, there was no significant
difference in MMSE score (F=0.939, P=0.392) or in
prevalence of cognitive impairment (F=0.939, P=0.392;
see Table 1). Furthermore, there was no significant differ-
ence in FSGs between those with or without cognitive
impairment (t=0.147, P=0.883; see Tables 3 and 4).
Association of cognitive impairment with FSI
In the different FSI groups, individuals with a normal
insulin level showed a significantly higher MMSE
score compared with those in the hypoinsulinemia
groups (t=2.160, P=0.031) and also showed a non-
significant increased prevalence of cognitive impair-
ment (χ2=2.960, P=0.228; see Table 2). There was
also no significant difference in FSI between those with
and without cognitive impairment (t=1.609, P=0.108;
see Table 3). Hypoinsulinemia nonsignificantly in-
creased the risk of cognitive impairment (see Table 5).
Discussion
This study examined the association between FSG
or FSI and cognitive impairment among Chinese
nonagenarians/centenarians. Using cross-sectional
observations, nonagenarians/centenarians from one
community who had no previous diagnosis of diabetes
Table 3 Baseline demographics based on cognitive function (n=661)




χ2 or t P value
Age (years) 93.52±3.37 93.73±3.40 93.17±3.28* 2.058 0.040
Gender (male/female) 216/444 127/125 90/319** 56.16 <0.0001
FSG (mmol/L) 4.46±1.45 4.45±1.52 4.47±1.40 0.147 0.883
FSI 6.27±2.27 6.45±2.39 6.16±2.18 1.609 0.108
DBP (mmHg) 72.59±12.06 72.08±12.08 72.91±12.05 0.864 0.388
SBP (mmHg) 139.71±23.31 139.71±23.31 140.07±22.63 0.199 0.862
TG (mmol/L) 1.22±0.64 1.19±0.54 1.24±0.70 1.074 0.283
TC (mmol/L) 4.15±0.85 4.06±0.86 4.20±0.84* 2.098 0.036
HDL (mmol/L) 1.58±0.59 1.59±0.66 1.57±0.54 0.759 0.222
LDL (mmol/L) 2.28±0.97 2.27±0.59 2.28±1.17 0.240 0.810
SUA (μmol/L) 318.72±87.01 321.17±92.73 316.88±82.53 0.623 0.534
BMI 19.05±3.64 18.93±3.25 19.11±3.85 0.629 0.530
Educational levels**
Illiteracy 479 128 351 0.100
Primary school 118 76 42 0.810
Secondary school 46 34 12
College and postgraduate 12 9 3 95.3 <0.0001
Baseline demographics were compared between groups with differing cognitive function scores. A P value of <0.05 was considered
statistically significant
SUA serum uric acid, BMI body mass index, FSG fasting serum glucose, FSI fasting serum insulin, HDL high density lipoprotein, LDL
low density lipoprotein, TC total cholesterol, TG triglyceride
*P<0.05; **P<0.01 vs. non-cognitively impaired using χ2 or Fisher’s exact tests (where an expected cell count was <5) for categorical
variables and unpaired Student’s t tests for continuous variables.
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showed a high prevalence of cognitive impairment
and hypoinsulinemia. The prevalence of impaired
fasting glucose was 4.99 %, and that of diabetes was
6.20 %. This study showed that among Chinese
nonagenarians/centenarians, cognitive function correlat-
ed with FSI and not FSG. Higher insulin levels may be a
preventative factor for cognitive impairment.
Insulin sensitivity declines and insulin resistance in-
creases with aging (Lin et al. 2011; Frisardi et al. 2010;
Barzilai et al. 2012; Penninx et al. 2009). In this study,
the prevalence of hypoinsulinemia was almost a third
higher (34.53 %) than in adults in general including
those aged over 60 years. However, in this sample where
a high prevalence of hypoinsulinemia existed, only
12.11 % of subjects showed abnormally high FSGs. If
a high prevalence of insulin resistance exists, those with
hypoinsulinemia are at risk for hyperglycosemia; thus,
the prevalence of insulin resistance in this sample is low.
In general, it is thought that insulin resistance and
hyperinsulinemia increase with aging (Lin et al. 2011;
Frisardi et al. 2010; Barzilai et al. 2012; Penninx et al.
2009), that in the elderly, obesity- and insulin-resistant
individuals are more long lived, and that mortality in the
elderly could lead to the retention of obesity- and
insulin-resistant individuals (Lamming et al. 2012;
Blanchard 2005; Andres 1980). However, our results
in this study of long-lived subjects provide contradictory
evidence. To the best of our knowledge, this study is the
only study to focus on FSI and FSG levels in
nonagenarians/centenarians. These data indicate that
the effectiveness and production of insulin in long-
lived subjects differs from adults in general. The mech-
anisms underlying these differences in long-lived sub-
jects compared with the elderly in general should be
examined in future studies.
In this study, the prevalence of both hypoinsulinemia
and cognitive impairment was high, FSI significantly
and positively correlated with cognitive score, and sub-
jects with hypoinsulinemia showed lower cognitive
function scores than those with normal insulin levels.
Together, these data show that insulin may play a key
role in cognitive function (Zhong et al. 2012; Shemesh
et al. 2012). Hypoinsulinemia may underlie cognitive
impairment in long-lived subjects. Previous studies pro-
vided evidence of the role insulin played in cognitive
processes; specifically, in hippocampal function, train-
ing on a spatial memory task increased hippocampal
insulin receptor expression and hypothalamic insulin-
regulated memory processes (Costello et al. 2012;
McNay and Recknagel 2011). Insulin receptors are also
found in the amygdala and other brain regions involved
in cognitive processes (Huang et al. 2010). Our study
Table 4 Odds risk (OR) of abnormal fasting serum glucose (FSG) on the prevalence of cognitive impairment in long-lived subjects
Normal (n=587) Impaired fasting glucose (n=33) Diabetes (n=41)
Number of cases
Unadjusted OR 1 (reference) 1.047 (0.543–2.019) 1.631 (0.642–4.146)
Model 1, adjusted OR 1 (reference) 0.906 (0.450–1.827) 1.125 (0.410–1.084)
Model 2, adjusted OR 1 (reference) 1.009 (0.508–2.007) 1.416 (0.543–3.694)
Model 3, adjusted OR 1 (reference) 0.948 (0.639–1.405) 1.129 (0.365–3.496)
Unadjusted a Wald χ2 test with df=1 was used (multiple logistic regression was used to adjust for covariates),Model 1 adjustment made
using the general covariates age, gender, and educational level,Model 2 adjustment made using components of metabolic syndrome (serum
lipid/lipoprotein, arterial blood pressure, body mass index, and serum uric acid), Model 3 adjustment made using all covariates
Table 5 Odds risk (OR) of hypoinsulinemia on the prevalence




Unadjusted OR 1 (reference) 0.777 (0.552–1.093)
Model 1, adjusted OR 1 (reference) 0.907 (0.627–1.313)
Model 2, adjusted OR 1 (reference) 0.832 (0.578–1.198)
Model 3, adjusted OR 1 (reference) 0.948 (0.639–1.405)
OR odds ratio, Unadjusted a Wald χ2 test with df=1 was used
(multiple logistic regression was used to adjust for covariates),
Model 1 adjustment made using the general covariates age,
gender, and educational levels, Model 2 adjustment made using
components of metabolic syndrome (serum lipid/lipoprotein,
arterial blood pressure, body mass index, and serum uric acid),
Model 3 adjustment made using all covariates
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provides important evidence from long-lived subjects in
a clinic trial setting; this was the interesting finding of
this study.
In our sample, the cognitive score was very low; 41
of 661 subjects showed a normal score, the mean score
was only 15.48, and the prevalence of serious cognitive
impairment was 61.8 % (almost two thirds). It has been
confirmed that individuals with cognitive impairment
show greater than double mortality rate than those with-
out cognitive impairment (Cano et al. 2012; Sachs et al.
2011). Insulin is an important hormone with essential
physiologic functions, and the high prevalence of
hypoinsulinemia may be a manifestation of the deterio-
ration in pancreatic island function with age. Individuals
with hypoinsulinemia may also show a high rate of
mortality (Langer et al. 1986). Therefore, due to this
increased rate of mortality, at advanced ages, only those
with both normal cognitive function and normal insulin
levels remain. This theory is conducive with the finding
that hypoinsulinemia correlated with cognitive impair-
ment. However, the high mortality rate could underlie
the phenomenon that more individuals with cognitive
impairment show hypoinsulinemia but cannot explain
the fact that FSI was significantly and positively corre-
lated with cognitive scores. Thus, insulin must play a
role in cognitive function.
Our study had some limitations that must be consid-
ered. First, 870 subjects aged 90 years or older
volunteered for the PLAD Study. Among these 870
volunteers, only 661 had nonmissing data for the two
main variables involved in this current analysis. Second,
due to the cross-sectional nature of this study, the subjects
might change their diets and the conditions related to the
association of FSG and FSI with cognitive impairment.
However, all of the nonagenarians/centenarians had lived
for long periods in the country in southwest China (an
underdeveloped area in China), and in that area, the diet
was typically vegetarian. The lifestyles and food habits of
the nonagenarians/centenarians were relatively consistent
and similar. Their diets and conditions were similar; thus,
it was impossible that diet and conditions affected the
results of this study. Third, due to the cross-sectional
nature of this study, we could not conduct analyses of
causes. Fourth, because this study is part of the PLAD
study, a survival bias may exist. However, this issue is
inherent in a study of individuals of this age group.
Finally, there was a difference in the prevalence of cogni-
tive impairment between genders. Gender may influence
the association of FSG or FSI with cognitive impairment.
Data analysis based on gender may remove this influence.
However, this analysis could reduce the sample size there-
by preventing the generation of a conclusion.
In summary, we observed that among long-lived
subjects, cognitive function appeared to correlate with
FSI, and higher FSI was associated with enhanced
cognitive function. Insulin and its role in cognitive
function must underlie this finding.
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